Levels of oxidative stress parameters and the protective effects of melatonin in psychosis model rat testis

Asian Journal of Andrology

Volumn 10, Issue 2, 2008, Pages 259-265

  Parlaktas, Bekir S ^a,b   Ozyurt, Birsen ^a   Ozyurt, Huseyin ^a   Tunc, Ayten T ^a   Akbas, Ali ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Antioxidant enzymes; Dizocilpine; Melatonin; Oxidative stress; Psychosis; Testis

Indexed keywords

CARBONYL DERIVATIVE; DIZOCILPINE; MALONALDEHYDE; MELATONIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NONHUMAN; OXIDATIVE STRESS; PSYCHOSIS; RAT; SPECTROPHOTOMETRY; TESTIS INJURY;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; MALE; MALONDIALDEHYDE; MELATONIN; MENTAL DISORDERS; NITRIC OXIDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; TESTIS;

EID: 40349089467     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1111/j.1745-7262.2008.00338.x     Document Type: Article

References (31)

1. Paulson L, Martin P, Ljung E, Blennow K, Davidsson P. Effects on rat thalamic proteome by acute and subchronic MK-801-treatment. Eur J Pharmacol 2004; 505: 103-9.
2. Rujescu D, Bender A, Keck M, Hartmann AM, Ohl F, Raeder H, et al. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: Molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 2006; 59: 721-9.
3. Smith JA, Boyer-Millar C, Goudie AJ. Does MK-801 discrimination constitute an animal model of schizophrenia useful for detecting atypical antipsychotics? Pharmacol Biochem Behav 1999; 64: 429-33.
4. Rung JP, Carlsson A, Rydén Markinhuhta K, Carlsson ML. (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 827-32.
5. Brown AS, Hembree WC, Friedman JH, Kaufmann CA, Gorman JM. The gonadal axis in men with schizophrenia. Psychiatry Res 1995; 57: 231-9.
6. Kaneda Y, Fujii A. Effects of chronic neuroleptic administration on the hypothalamo-pituitary-gonadal axis of male schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry 2000; 24: 251-8.
7. Mann K, Rossbach W, Müller MJ, Müller-Siecheneder F, Pott T, Linde I, et al. Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine. Psychoneur-oendocrinology 2006; 31: 256-64.
8. El-Sokkary GH, Khidr BM, Younes HA. Role of melatonin in reducing hypoxia-induced oxidative stress and morphological changes in the liver of male mice. Eur J Pharmacol 2006; 540: 107-14.
9. Zini A, Schlegel PN. Effect of hormonal manipulation on mRNA expression of antioxidant enzymes in the rat testis. J Urol 2003; 169: 767-71.
10. Sikka SC. Relative impact of oxidative stress on male reproductive function. Curr Med Chem 2001; 8: 851-62.
11. Murugesan P, Muthusamy T, Balasubramanian K, Arunakaran J. Studies on the protective role of vitamin C and E against polychlorinated biphenyl (Aroclor 1254)-induced oxidative damage in Leydig cells. Free Radic Res 2005; 39: 1259-72.
12. Tan DX, Reiter RJ, Manchester LC, Yan M, El-Sawi M, Sainz RM, et al. Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2: 181-97.
13. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 34: 1-10.
14. Armagan A, Uz E, Yilmaz HR, Soyupek S, Oksay T, Ozcelik N. Effects of melatonin on lipid peroxidation and antioxidant enzymes in streptozotocin-induced diabetic rat testis. Asian J Androl 2006; 8: 595-600.
15. Oner-Iyidogan Y, Gürdöl F, Oner P. The effects of acute melatonin and ethanol treatment on antioxidant enzyme activities in rat testes. Pharmacol Res 2001; 44: 89-93.
16. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
17. Durak I, Yurtarslani Z, Canbolat O, Akyol O. A methodological approach to superoxide dismutase (SOD) activity assay based on inhibition of nitroblue tetrazolium (NBT) reduction. Clin Chim Acta 1993; 214: 101-3.
18. Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121-6.
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
20. Wasowicz W, Nève J, Peretz A. Optimized steps in fluoro-metric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39: 2522-6.
21. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. In: Methods in Enzimology and Oxygen Radicals in Biological Systems, Vol. 186, New York: Academic Press, 2000, p 464-78.
22. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-3.
23. Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L. Oxidative stress involvement in schizophrenia pathophy-siology: A review. Encephale 2006; 32: 244-52.
24. Sheweita SA, Tilmisany AM, Al-Sawaf H. Mechanisms of male infertility: role of antioxidants. Curr Drug Metab 2005; 6: 495-501.
25. Dandekar SP, Nadkarni GD, Kulkarni VS, Punekar S. Lipid peroxidation and antioxidant enzymes in male infertility. JPGM 2002; 48: 186-9.
26. Sharma RK, Agarwal A. Role of reactive oxygen species in male infertility. Urology 1996; 48: 835-50.
27. Baumber J, Ball BA, Gravance CG, Medina V, Davies-Morel MC. The effect of reactive oxygen species on equine sperm motility, viability, acrosomal integrity, mitochondrial membrane potential, and membrane lipid peroxidation. J Androl 2000; 21: 895-902.
28. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martin V, et al. Regulation of antioxidant enzymes: A significant role for melatonin. J Pineal Res 2004; 36: 1-9.
29. Sener G, Sehirli AÖ, Paskaloglu K, Dülger GA, Alican I. Melatonin treatment protects against ischemia/reperfusion-induced functional and biochemical changes in rat urinary bladder. J Pineal Res 2003; 34: 226-30.
30. Takarada T, Hinoi E, Balcar VJ, Taniura H, Yoneda Y. Possible expression of functional glutamate transporters in the rat testis. J Endocrinol 2004; 181: 233-44.
31. Ozyurt B, Parlaktas BS, Ozyurt H, Aslan H, Ekici F, Atis O. A preliminary study of the levels of testis oxidative stress parameters after MK-801-induced experimental psychosis model: Protective effects of CAPE. Toxicology 2007; 230: 83-9.